The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 1997;337(18):1327.

Original Article
PreviousPrevious
Volume 337:154-160 July 17, 1997 Number 3
NextNext

Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism
Jacob H. Rand, M.D., Xiao-Xuan Wu, M.D., Harry A.M. Andree, M.D., Ph.D., Charles J. Lockwood, M.D., Seth Guller, Ph.D., Jonathan Scher, M.D., and Peter C. Harpel, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
ABSTRACT

Background The mechanisms of vascular thrombosis and pregnancy loss in the antiphospholipid-antibody syndrome are unknown. Levels of annexin V, a phospholipid-binding protein with potent anticoagulant activity, are markedly reduced on placental villi from women with this syndrome. Hypercoagulability in such women may therefore be due to the reduction of surface-bound annexin V by antiphospholipid antibodies. To test this idea, we studied how antiphospholipid antibodies affect levels of annexin V on cultured trophoblasts and human umbilical-vein endothelial cells and how they affect the procoagulant activity of these cells.

Methods We isolated IgG fractions from three patients with the antiphospholipid-antibody syndrome and from normal controls. These antibodies were incubated with cultured BeWo cells (a placental-trophoblast cell line), primary cultured trophoblasts, and human umbilical-vein endothelial cells. Annexin V on the cell surfaces was measured by an enzyme-linked immunosorbent assay. The coagulation times of plasma overlaid on the cells were also determined.

Results Trophoblasts and endothelial cells exposed to antiphospholipid-antibody IgG as compared with control IgG had reduced levels of annexin V (trophoblasts, 0.37±0.02 vs. 0.85±0.12 ng per well, P = 0.02; endothelial cells, 1.6±0.04 vs. 2.1±0.05 ng per well, P = 0.001). Also, trophoblasts and endothelial cells exposed to antiphospholipid-antibody IgG had faster mean (±SE) plasma coagulation times than cells exposed to control IgG (trophoblasts, 8.7±2.0 vs. 21.3±2.9 minutes, P = 0.02; endothelial cells, 9.8±0.8 vs. 14.2±1.2 minutes, P = 0.04).

Conclusions Antiphospholipid antibodies reduce the levels of annexin V and accelerate the coagulation of plasma on cultured trophoblasts and endothelial cells. The reduction of annexin V levels on vascular cells may be an important mechanism of thrombosis and pregnancy loss in the antiphospholipid-antibody syndrome.


Source Information

From the Department of Medicine, Divisions of Hematology (J.H.R., X.-X.W., P.C.H.) and Thrombosis (H.A.M.A.), and the Department of Obstetrics, Gynecology, and Reproductive Science (J.S.), Mount Sinai School of Medicine; and the Department of Obstetrics and Gynecology (C.J.L., S.G.) New York University School of Medicine — all in New York.

Address reprint requests to Dr. Rand at the Hematology Division, Mount Sinai Medical Center, Box 1079, 5 E. 98th St., New York, NY 10029.

Full Text of this Article


Related Letters:

Antiphospholipid Antibodies, Annexin V, and Pregnancy Loss
Rote N. S., Cheng H.-M., Rand J. H., Harpel P., Lockwood C.
Extract | Full Text  
N Engl J Med 1997; 337:1630-1631, Nov 27, 1997. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved.